Viewed: 224
Emailed: 0
PDF Downloaded: 1175
Full Text PDF Share on Facebook Share on Twitter
Original Article
Author Details :
Volume : 13, Issue : 1, Year : 2023
Article Page : 222-226
https://10.18231/j.pjms.2023.044
Abstract
Background: Retroperitoneal masses constitute a heterogeneous group of uncommon lesions and represent a challenge due to overlapping imaging findings. Most are malignant lesions.
Aims: To evaluate the role of CT in the detection, localization and characterization of retroperitoneal masses and to compare and correlate with post-surgical evaluation and histological evaluation whenever possible.
Materials and Methods: The cross-sectional study carried out in the Department of Radiodiagnosis for a period of 2 years. Present study involved 50 patients of either sex belonging to various age groups. The CT scan findings were correlated with the findings at surgery and histopathological examination.
Results: Renal masses were the most common retroperitoneal mass(48%). Renal cell carcinoma was the most common renal tumour (66.6%)and pancreatic adenocarcinoma was the most common pancreatic tumour (68.7%). Majority of cases of retroperitoneal mass were in the age group 51-70 years. Males were affected more than females in a ratio of 1.94: 1. Mass in the abdomen was the most common clinical presenting feature (40%). CT accuracy in the diagnosis of retroperitoneal tumours was 96%.
Conclusions: CT is an essential diagnostic modality in diagnosing and characterizing retroperitoneal masses. It establishes the location of such masses and shows in great detail the associated findings.
Keywords: Retroperitoneal masses, Renal cell carcinoma, Pancreatic adenocarcinoma
How to cite : Nayak P K, Rao M, Jena S K, Kumar B A, A clinical study to evaluate the role of CT in the detection, localization and characterization of retroperitoneal masses. Panacea J Med Sci 2023;13(1):222-226
Copyright © 2023 by author(s) and Panacea J Med Sci. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License (creativecommons.org)